STRAGEN is an independent Swiss company founded in 1990, specialized in the development and commercialization of niche Generic and Generic+ pharmaceuticals, innovative consumer health products, and in the early-stage development of new drugs. STRAGEN also offers a range of specifically tailored consulting services for pharmacovigilance and clinical development strategies.
D-40: For more than 10 consecutive years, Stragen attends the CPhI worldwide meeting. This year the event occurs from…read more
STRAGEN Team is getting ready for Vitafoods 2018, The Global Nutraceutical event…read more
We are pleased to share the new Leviker® & SniZtop® Facebook & Instagram pages…read more